Utah Medical Products UTMD Neonatal — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's neonatal — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Utah Medical Products's neonatal — revenue?
- Utah Medical Products (UTMD) reported neonatal — revenue of $1.57M in Q1 2026.
- How has Utah Medical Products's neonatal — revenue changed year-over-year?
- Utah Medical Products's neonatal — revenue decreased by 20.8% year-over-year, from $1.98M to $1.57M.
- What is the long-term trend for Utah Medical Products's neonatal — revenue?
- Over 4 years (2021 to 2025), Utah Medical Products's neonatal — revenue has grown at a 4.5% compound annual growth rate (CAGR), from $8.04M to $9.6M.
- What does neonatal — revenue mean?
- This metric represents the total net sales generated from the sale of medical devices specifically designed for neonatal critical care and perinatology applications. It reflects the company's ability to monetize its specialized product portfolio within the high-acuity hospital segment, excluding any pass-through taxes. Tracking this revenue stream provides insight into the market demand and competitive positioning of the firm's neonatal product line.